Marksans Pharma P/B Ratio
Marksans Pharma (MARKSANS) P/B ratio is 4.0 (High), book value per share ₹671.78 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see MARKSANS share price.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
MARKSANS P/B Ratio — Valuation Insights & Book Value Analysis
Marksans Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 4.0 (High). Review Marksans Pharma P/E valuation to evaluate earnings-based valuation against sector peers.
- Stock appears overvalued with PB of 4.0, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 925.6% above historical average
- Trading at premium to sector average PB of -0.31
Marksans Pharma P/B Ratio Historical Trend
MARKSANS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Marksans Pharma 52-week for the annual high/low range and current price position.
MARKSANS Historical P/B Ratio — Book Value Per Share & Year-End Price
Marksans Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.37 | ₹671.78 | ₹246.30 | ₹3,023 | Low |
| 2025 | 0.33 | ₹553.11 | ₹180.29 | ₹2,489 | Low |
| 2024 | 0.64 | ₹463.56 | ₹296.65 | ₹2,086 | Low |
| 2023 | 0.41 | ₹392.22 | ₹161.10 | ₹1,765 | Low |
| 2022 | 0.2 | ₹298.29 | ₹58.25 | ₹1,223 | Low |
MARKSANS vs Healthcare Peers — P/B Ratio Comparison
Marksans Pharma P/B 4.0 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |